Viking Therapeutics is mispriced due to the successful but misunderstood clinical results of their oral GLP-1 treatment. Read ...
As David Patterson observed in 1980, “A RISC potentially gains in speed merely from a simpler design.” Patterson’s principle of simplicity underpins a new alternative to speculation: A deterministic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback